Suppr超能文献

基于F-FDG PET影像组学、代谢参数和临床因素的老年弥漫性大B细胞淋巴瘤患者预后模型的开发与验证

Development and validation of prognostic models based on F-FDG PET radiomics, metabolic parameters, and clinical factors for elderly DLBCL patients.

作者信息

Yang Tianshuo, Sun Zhuxu, Shi Yuye, Teng Yue, Cheng Luyi, Zhu Ronghua, Zhang Huai, Wang Qiuhu, Wei Jing, Ding Chongyang, Tao Weijing

机构信息

Department of Nuclear Medicine, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.

Department of Hematology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.

出版信息

Ann Hematol. 2024 Dec;103(12):5583-5598. doi: 10.1007/s00277-024-06071-6. Epub 2024 Oct 31.

Abstract

This study aimed to assess the predictive value of baseline F-FDG PET radiomics features, metabolic parameters, and clinical factors for PFS and OS in elderly DLBCL patients. Using LASSO COX regression, we derived Radscore from PET radiomics features. We constructed and externally validated prognostic models, evaluating their performance through various metrics. From 341 training set patients and 83 external validation set patients revealed significant correlations between PET radiomics features and survival outcomes. Multivariate COX analysis identified associations of radiomics features (Radscore), metabolic parameters (TMTV, Dmax), and clinical factors (ECOG PS, hemoglobin level) with PFS and OS. In external validation, the combined model incorporating radiomic features, metabolic parameters, and clinical factors showed superior predictive performance for PFS and OS compared to other models. The combined model had higher C-index values for both PFS and OS, and its td-ROC curves exhibited significantly higher AUCs. Calibration curves demonstrated good consistency, and DCA revealed a higher net benefit for the combined model. In conclusion, the combined model that incorporated F-FDG PET radiomics features, metabolic parameters, and clinical factors demonstrated superior prognostic predictive ability, providing a useful tool for personalized treatment decisions in elderly DLBCL patients.

摘要

本研究旨在评估基线F-FDG PET影像组学特征、代谢参数和临床因素对老年弥漫性大B细胞淋巴瘤(DLBCL)患者无进展生存期(PFS)和总生存期(OS)的预测价值。我们使用LASSO COX回归从PET影像组学特征中得出Radscore。我们构建并外部验证了预后模型,并通过各种指标评估其性能。在341例训练集患者和83例外部验证集患者中,PET影像组学特征与生存结果之间存在显著相关性。多变量COX分析确定了影像组学特征(Radscore)、代谢参数(总代谢肿瘤体积、最大标准化摄取值)和临床因素(东部肿瘤协作组体能状态、血红蛋白水平)与PFS和OS的关联。在外部验证中,结合影像组学特征、代谢参数和临床因素的联合模型在PFS和OS方面显示出比其他模型更好的预测性能。联合模型在PFS和OS方面均具有更高的C指数值,其时间依赖ROC曲线显示出显著更高的曲线下面积(AUC)。校准曲线显示出良好的一致性,决策曲线分析(DCA)表明联合模型具有更高的净效益。总之,结合F-FDG PET影像组学特征、代谢参数和临床因素的联合模型显示出卓越的预后预测能力,为老年DLBCL患者的个性化治疗决策提供了一个有用的工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验